CVS reported a 5.7 percent rise in sales and improved adjusted EBITDA for the four months to 31 October 2025, supported by stronger like for like growth and continued membership gains in its Healthy Pet Club scheme...
CVS reported a 5.7 percent rise in sales and improved adjusted EBITDA for the four months to 31 October 2025, supported by stronger like for like growth and continued membership gains in its Healthy Pet Club scheme...